Aurobindo Pharma Ltd.
SET SMS ALERT
| 5-Day | 98,571 |
| 10-Day | 144,543 |
| 30-Day | 161,148 |
| 5-Day | 98,571 |
| 10-Day | 144,543 |
| 30-Day | 161,148 |
Depth
Market Depth (20 Nov 2018)
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 50 | 779.15 | 780.00 | 8 |
| 50 | 779.10 | 780.75 | 100 |
| 1477 | 777.80 | 782.95 | 10 |
| 3 | 777.50 | 783.80 | 96 |
| 5 | 776.60 | 784.90 | 10 |
| 2790 | Total | 14.3 K | Total |
Buy Qty
2790
Sell QTY
14.3 K
| 5-Day | 1,679,761 |
| 10-Day | 2,292,292 |
| 30-Day | 2,639,774 |
| 5-Day | 1,679,761 |
| 10-Day | 2,292,292 |
| 30-Day | 2,639,774 |
- Quote
- CHARTS
- NEWS
- COMMENTS31 new
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
Aurobindo Pharm
Sentimeter
100% of moneycontrol users recommend buying Aurobindo Pharm.
What's your call on Aurobindo Pharm today?
Read 31 investor views
Top Trading Ideas
9 November 2018
buy UPL Nov Fut |
Entry Price (Rs) 732.00 |
Exit Price (Rs) 738.50 |
Gain (Rs) 7.00 |
buy LICHousingFin Nov Fut |
Entry Price (Rs) 434.15 |
Exit Price (Rs) 442.65 |
Gain (Rs) 9.00 |
| Days | BSE | NSE |
| 30 | 766.47 | 767.34 |
| 50 | 764.40 | 765.07 |
| 150 | 661.77 | 662.13 |
| 200 | 644.99 | 645.27 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Aurobindo Pharm
| Standalone | Sep'18 | Jun'18 | Mar'18 | Dec'17 |
| Net Sales | 3,090.38 | 2,491.62 | 2,296.32 | 2,620.35 |
| Other Income | 4.18 | 2.82 | 6.36 | 33.79 |
| PBDIT | 606.97 | 396.76 | 477.88 | 664.30 |
| Net Profit | 380.95 | 225.12 | 308.29 | 444.32 |
(In Rs Cr)
| Total Share Capital | 58.59 |
| Net Worth | 9,982.58 |
| Total Debt | 3,653.83 |
| Net Block | 3,392.97 |
| Investments | 1,967.50 |
| Total Assets | 13,636.41 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 525.50 | -0.95 | 678.80 | 434.80 | 126,084.70 |
| Aurobindo Pharm | 778.40 | -1.89 | 826.35 | 527.05 | 45,607.05 |
| Cipla | 521.30 | -1.40 | 678.00 | 508.10 | 41,977.79 |
| Piramal Enter | 2281.90 | -3.27 | 3302.55 | 1796.75 | 41,686.77 |
| Dr Reddys Labs | 2450.25 | -3.04 | 2687.45 | 1888.00 | 40,685.39 |
| More » | |||||
| Sep' 18 | Jun' 18 | Jun' 17 | Mar' 17 | |
| Promoter | 51.87 | 51.87 | 51.87 | 51.87 |
| Public (FII + DII) | 48.13 | 48.13 | 48.13 | 48.13 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| HDFC Balanced Advantage Fund (G) | 8,128,855 |
| HDFC Hybrid Equity Fund (G) | 5,962,188 |
| HDFC Equity Fund (G) | 4,529,480 |
| HDFC Top 100 Fund (G) | 3,172,450 |
HDFC Bank Recommended on Jun 5th 2017
Recommended price 1,636.00 | Peak from reco 2219.05 35.66%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
About Aurobindo Pharm
Aurobindo Pharm is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 45,607.05 crore.
The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P Sarath Chandra Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, M Sitarama Murthy - Non Exe. & Ind. Director, Avnit Bimal Singh - Non Exe. & Ind. Director, Savita Mahajan - Addnl.Non Exe.Independent Director.
It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA.
Its Registered office is at Plot No.2, Maitri Vihar, Ameerpet,, Hyderabad,Telangana - 500038.
Their Registrars are Karvy Computershare Private Ltd.
